Sanofi Reaches Out to 340B Entities that Complained to HRSA About its Contract Pharmacy Restrictions

Sanofi has sent letters to 340B covered entities that have complained to HRSA about the drug manufacturer's denials of 340B pricing on drugs shipped to contract pharmacies.

Drug manufacturer Sanofi has sent letters to 340B covered entities that have complained to federal authorities about its denials of 340B pricing on drugs shipped to contract pharmacies, covered entity representatives say.

Sanofi has acknowledged but not responded to requests

Read More »

Biden Administration Moves a Step Closer to Trashing Trump’s 340B Health Center Insulin/EpiPen Rule

Former President Trump signed an executive order in July 2020 directing HHS to limit what 340B health centers can charge patients for insulin and EpiPen-type devices.

The dumping of a controversial Trump administration rule limiting what 340B health centers can charge patients for insulin and EpiPen-type devices took a big step closer to being finalized last week.

Late last week Thursday, the U.S. Health Resources

Read More »
Industry Insights Logo

Keys to Ensuring Adherence in HIV Treatment and Care

SPONSORED CONTENT

An HIV diagnosis does not have the same meaning today as when the virus first emerged in the 1980s. People living with HIV can now expect to live a long, full life, as long as they adhere to a prescribed antiretroviral treatment regimen.

Read More »

Arkansas Insurance Dept. to Rule Next Month on PhRMA’s Petition to Block Novel 340B Contract Pharmacy Law

An Arkansas Insurance Department hearing officer said last week she would decide by Oct. 13 whether to stay enforcement of a state law requiring drug manufacturers to honor 340B contract pharmacy arrangements.

An Arkansas Insurance Department hearing officer said last week she would decide by Oct. 13 whether to stay enforcement of a state law requiring drug manufacturers to honor 340B contract pharmacy arrangements pending resolution of a bevy of federal lawsuits

Read More »

U.S. Supreme Court Gets Several Briefs Urging Rejection of CMS’s Drug Payment Cuts for 340B Hospitals

Nine friend-of-the-court briefs have been filed urging the U.S. Supreme Court to strike down the CMS rule that imposed a huge cut in 340B hospitals’ Medicare reimbursement for physician administered drugs.

Nine friend-of-the-court briefs have been filed in the nation’s highest court urging rejection of an appeals court’s decision last year that upheld a huge cut in 340B hospitals’ Medicare reimbursement for physician administered drugs.

Thirty-seven state and regional hospital associations

Read More »

Napo Pharmaceuticals Tells Entities How They Can Keep Getting 340B Price on Limited-Distribution Drug

Napo Pharmaceuticals has told covered entities how they can continue to buy Mytesi, an antidiarrheal for patients living with HIV/AIDS who take antiretroviral drugs, at its 340B price.

Napo Pharmaceuticals yesterday posted a public notice to 340B covered entities about how to obtain 340B pricing on Mytesi, an antidiarrheal for patients living with HIV/AIDS who take antiretroviral drugs.

Napo said in the notice on the U.S. Health

Read More »

340B INDUSTRY LEADER SPOTLIGHT

Jeff Spencer, Senior Director, Sales and Account Management, Omnicell 340B

Jeff Spencer headshot
Jeff Spencer

Q: Where did you grow up?

I grew up in Alpharetta, GA, near Atlanta and have spent the last 17 years in Charlotte, NC.

Q: Where did you go to college/graduate school?

University of Georgia

Q: What are your favorites?

Food: Any fresh seafood but especially grouper and oysters.

Movie: A River Runs Through It

Read More »

News Alert: Key House Committee Excludes “Spread Pricing” Language that 340B Entities Feared from Drug Pricing Legislation

The House Energy & Commerce Committee excluded spread-pricing language that 340B entities feared from forthcoming drug pricing legislation.

340B covered entities are breathing easier today upon learning that U.S. House Democrats excluded much-feared Medicaid managed care “spread pricing” language from forthcoming drug pricing legislation.

The House Energy & Commerce Committee late yesterday released the text of the 16

Read More »

In Largely Symbolic Move, Becerra Expresses “Strong Support” for 340B in Drug Pricing Plan

HHS Secretary Xavier Becerra yesterday expressed "strong support" for the 340B program in a drug pricing report to the White House, but recommended no changes to the program.

U.S. Health and Human Services Secretary Xavier Becerra yesterday reiterated HHS’ “strong support for the 340B Drug Pricing Program” in a 29-page plan to lower drug prices.

Becerra’s Sept. 9 report to White House domestic and economic policy counselors

Read More »

N.C. Lawmakers Leave 340B DSH, Children’s, and Cancer Hospitals and HTCs Unprotected from PBM Pickpocketing

Hospital sign
North Carolina lawmakers excluded 340B disproportionate share hospitals, children’s hospitals, free-standing cancer hospitals, and hemophilia treatment centers from protection against discriminatory PBM treatment under a bill passed and sent to the governor this week.

North Carolina lawmakers approved a final deal Wednesday to protect some, but not all, of the state’s 340B covered entities against discrimination by pharmacy benefit managers (PBMs).

Under an agreement a House-Senate conference committee reached on Sept. 8, 340B

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live